NCM
ADCT icon

Nantahala Capital Management’s ADC Therapeutics ADCT Stock Holding History

Nantahala Capital Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21M Buy
5,597,433
+122,000
+2% +$481K 1.31% 35
2025
Q4 		$19.3M Buy
5,475,433
+3,209,144
+142% +$13M 1.15% 35
2025
Q3 		$9.07M Hold
2,266,289
– – 0.56% 73
2025
Q2 		$6.07M Buy
+2,266,289
New +$4.77M 0.43% 80
2023
Q4 		– Sell
-257,162
Closed -$231K – 129
2023
Q3 		$231K Sell
257,162
-582,838
-69% -$775K 0.03% 119
2023
Q2 		$1.81M Hold
840,000
– – 0.22% 80
2023
Q1 		$1.64M Buy
840,000
+596,710
+245% +$2.2M 0.16% 80
2022
Q4 		$934K Buy
+243,290
New +$973K 0.08% 89

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return